跳至主要内容
临床试验/NCT03020472
NCT03020472终止4 期

U19 Year 6: Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age, SLVP016

Stanford University2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2008年11月最近更新:
适应症

试验速览

阶段
4 期
状态
终止
入组人数
6
试验地点
2
主要终点
Number of Participants Who Received Influenza Vaccine

研究概览

简要总结

This pilot study will investigate B-cell responses following vaccination with live, attenuated influenza vaccine (LAIV) in healthy children 2 years of age from blood samples taken at designated time points before and after vaccination.

详细描述

This is an exploratory study to determine the peripheral antibody secreting cell response during Days 5-13 after immunization with live, attenuated influenza vaccine (LAIV).

Investigators hoped to enroll 27 healthy children, 2 years of age who had not had any prior LAIV or trivalent inactivated vaccine (TIV) within the past 2 years. Due to low enrollment, the study was halted. Due to the limited number of samples, no analysis was performed.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
24 Months 至 35 Months(Child)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Number of Participants Who Received Influenza Vaccine

时间窗: Day 0 to Day 28

次要结局

  • Number of Participants With Related Adverse Events(Day 0 to Day 28)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Philip Grant

Assistant Professor of Medicine (Infectious Diseases)

Stanford University

研究点 (2)

Loading locations...

相似试验